Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 33522-95-1
2. (5alpha)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
3. (-)-noroxymorphone
4. En 3169
5. 7,8-dihydro-14-hydroxynormorphinone
6. 14-hydroxydihydronormorphinone
7. 9nz7111a9o
8. Nor Oxymorphone
9. Unii-9nz7111a9o
10. Einecs 251-561-5
11. Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-, (5.alpha.)-
12. Schembl136548
13. Noroxymorphone [who-dd]
14. Dtxsid80955145
15. Chebi:187724
16. Zinc2522694
17. En-3169
18. 4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
19. 4,5alpha-epoxy-3,14-dihydroxy Morphinan-6-one
20. Q25102255
21. (5.alpha.)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
22. Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-, (5alpha)-
23. Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy- (8ci)
24. Oxycodone Hydrochloride, Noroxymorphone- [usp Impurity]
25. Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-, (5alpha)- (9ci)
26. Naloxone Hydrochloride Dihydrate Impurity A [ep Impurity]
27. (4r,4as,7ar,12bs)-4a,9-dihydroxy-1,2,3,4,5,6,7a,13-octahydro-4,12-methanobenzouro[3,2-e]isoquinolin-7-one
28. (4r,4as,7ar,12bs)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7ah)-one
Molecular Weight | 287.31 g/mol |
---|---|
Molecular Formula | C16H17NO4 |
XLogP3 | 0.4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 0 |
Exact Mass | 287.11575802 g/mol |
Monoisotopic Mass | 287.11575802 g/mol |
Topological Polar Surface Area | 78.8 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 511 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A Noroxymorphone API manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Noroxymorphone API, including repackagers and relabelers. The FDA regulates Noroxymorphone API manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Noroxymorphone API API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Noroxymorphone API supplier is an individual or a company that provides Noroxymorphone API active pharmaceutical ingredient (API) or Noroxymorphone API finished formulations upon request. The Noroxymorphone API suppliers may include Noroxymorphone API API manufacturers, exporters, distributors and traders.
Noroxymorphone API Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Noroxymorphone API GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Noroxymorphone API GMP manufacturer or Noroxymorphone API GMP API supplier for your needs.
A Noroxymorphone API CoA (Certificate of Analysis) is a formal document that attests to Noroxymorphone API's compliance with Noroxymorphone API specifications and serves as a tool for batch-level quality control.
Noroxymorphone API CoA mostly includes findings from lab analyses of a specific batch. For each Noroxymorphone API CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Noroxymorphone API may be tested according to a variety of international standards, such as European Pharmacopoeia (Noroxymorphone API EP), Noroxymorphone API JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Noroxymorphone API USP).
LOOKING FOR A SUPPLIER?